Abstract
A QSAR study is reported to predict the binding affinity of a set of 81 modulators for both of human estrogen receptor α and β (ERα and ERβ). In this study, the derived QSAR models were built by forward stepwise multilinear regression (MLR) and nonlinear radial basis function neural networks (RBFNN), respectively. The statistical characteristics of the external test set provided by multiple linear model (R2=0.814, F=61.277, RMS=0.5461 for ERα; R2=0.600, F=21.039, RMS=0.6707 for ERβ) indicated satisfactory stability and predictive ability of the model built. The predictive ability for ERβ of RBFNN model is somewhat superior: R2=0.7691, F=32.012, RMS=0.5764, and the similar result was obtained for ERα of the test set: R2=0.7950, F=54.131 RMS=0.3120. Overall, the appropriate results proved the models to be meaningful and useful to predict and virtual screen of the derivatives with high binding activity.
Keywords: Quantitative Structure-Activity Relationships (QSAR), hERα, hERβ, Multiple Linear Regression (MLR), Radial Basis Function Neural Networks (RBFNN), Binding activity.
Letters in Drug Design & Discovery
Title:Prediction of the Estrogen Receptor Binding Affinity for both hERα and hERβ by QSAR Approaches
Volume: 11 Issue: 3
Author(s): Changliang Deng, Xuanxuan Chen, Hongying Lu, Xin Yang, Feng Luan and Maria Natalia Dias Soeiro Cordeiro
Affiliation:
Keywords: Quantitative Structure-Activity Relationships (QSAR), hERα, hERβ, Multiple Linear Regression (MLR), Radial Basis Function Neural Networks (RBFNN), Binding activity.
Abstract: A QSAR study is reported to predict the binding affinity of a set of 81 modulators for both of human estrogen receptor α and β (ERα and ERβ). In this study, the derived QSAR models were built by forward stepwise multilinear regression (MLR) and nonlinear radial basis function neural networks (RBFNN), respectively. The statistical characteristics of the external test set provided by multiple linear model (R2=0.814, F=61.277, RMS=0.5461 for ERα; R2=0.600, F=21.039, RMS=0.6707 for ERβ) indicated satisfactory stability and predictive ability of the model built. The predictive ability for ERβ of RBFNN model is somewhat superior: R2=0.7691, F=32.012, RMS=0.5764, and the similar result was obtained for ERα of the test set: R2=0.7950, F=54.131 RMS=0.3120. Overall, the appropriate results proved the models to be meaningful and useful to predict and virtual screen of the derivatives with high binding activity.
Export Options
About this article
Cite this article as:
Deng Changliang, Chen Xuanxuan, Lu Hongying, Yang Xin, Luan Feng and Cordeiro Natalia Dias Soeiro Maria, Prediction of the Estrogen Receptor Binding Affinity for both hERα and hERβ by QSAR Approaches, Letters in Drug Design & Discovery 2014; 11 (3) . https://dx.doi.org/10.2174/15701808113109990067
DOI https://dx.doi.org/10.2174/15701808113109990067 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Medical Data Assessment with Traditional, Machine-learning and Deeplearning Techniques
Current Medical Imaging Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
Current Pharmaceutical Design Metabolism and Toxicological Implications of Commonly Used Chemopreventive Drugs Against Breast Cancer/Carcinogenesis
Current Drug Metabolism Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development
Current Cancer Drug Targets Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Current Gene Therapy Apoptosis and Apoptosis-Based Therapy in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
Current Cancer Drug Targets Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters Renal Solute Transporters and Their Relevance to Serum Urate Disorder
Current Hypertension Reviews KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives
Current Molecular Medicine Challenges in the Correct Assessment of a Case of Aggressive Thyroid Carcinoma with Synchronous Breast Cancer: A Case Report and Review of the Literature of Essential Role of Radiopharmaceuticals
Current Radiopharmaceuticals Regulation of Polymorphonuclear Leukocyte-Intestinal Epithelial Cell Interactions: Signalling Events and Potential Drug Targets
Current Signal Transduction Therapy S100A8/A9 as a Pro-inflammatory Cytokine in Obstructive Airway Disease Via the Multi-Ligand Receptor, RAGE
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Molecular Determinants of Fluoroquinolone Antibacterial Agents Pharmacokinetics
Current Clinical Pharmacology Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry Applications of FDG-PET/CT in Assessment of Vascular Infection and Inflammation
Current Molecular Imaging (Discontinued) Lentiviral Vectors: A Versatile Tool to Fight Cancer
Current Molecular Medicine Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
Current Medicinal Chemistry Vitamin D Analogs as Modulators of Vitamin D Receptor Action
Current Topics in Medicinal Chemistry Molecular Docking, Drug-Likeness and ADMET Analysis, Application of Density Functional Theory (DFT) and Molecular Dynamics (MD) Simulation to the Phytochemicals from Withania Somnifera as Potential Antagonists of Estrogen Receptor Alpha (ER- α)
Current Computer-Aided Drug Design